Conference Coverage

Chlamydia infections associated with more than a doubling of ovarian cancer risk

Publish date: March 16, 2018

 

FROM THE AACR ANNUAL MEETING


Neither cohort showed any significant association of ovarian cancer with any of the other antibodies, Dr. Trabert said.

The NCI Intramural Research Program supported the study. Dr. Trabert and her colleagues declared no conflicts of interest.

SOURCE: Trabert et al. Abstract 4942.

Pages

Recommended Reading

International parental attitudes of HPV vaccination have similarities, differences
MDedge Family Medicine
Strategies to evaluate postmenopausal bleeding
MDedge Family Medicine
Parents have diverse reasons for refusing HPV vaccine for their child
MDedge Family Medicine
Adolescents with chronic health conditions often undervaccinated
MDedge Family Medicine
FDA: Laparoscopic power morcellators can spread malignant cells when used in women with occult uterine cancers*
MDedge Family Medicine
New multi-analyte blood test shows promise in screening for several common solid tumors
MDedge Family Medicine
USPSTF: Routine screens for ovarian cancer not recommended
MDedge Family Medicine
FDA approves new HPV assay
MDedge Family Medicine
Telling her she has cancer: A patient-centered approach to breaking bad news
MDedge Family Medicine
FDA authorizes first direct-to-consumer BRCA1/2 test
MDedge Family Medicine